Vysioneer
Cambridge, US · Founded 2019 · Delaware corporation · 11 employees on LinkedIn · 1 known investors
Vysioneer builds AI software that analyzes tumor lesions in medical imaging to assess treatment efficacy, aiming to make oncology clinical trials smaller and faster. It serves cancer researchers and drug developers by extracting all-lesion features and biomarkers that predict treatment outcomes.
Founders & leadership
Vysioneer was founded in 2019 by Jen-Tang Lu.
JL
Jen-Tang LuFounder
YY
Yu-Shan YangNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$2.8M disclosed across 3 rounds · 2019–2023
▶$750KraisedJun 2023 · 1 investors · Other TechnologyRule 506(b)
▶$750KraisedJun 2023 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Yu-Shan YangExecutive Officer, Director
- Jen-Tang LuExecutive Officer, Director
- Luke ArmourDirector
- Amount sold
- $750K
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$1.5MraisedJan 2021 · 5 investors · Other TechnologyRule 506(b)
▶$1.5MraisedJan 2021 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Yu-Shan YangExecutive Officer, Director
- Jen-Tang LuExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Minimum investment
- $1
- First sale
- Dec 2020
- Incorporated
- Corporation, Massachusetts, 2019
- Federal exemptions
- 06b
▶$500KraisedSep 2019 · 6 investors · Other TechnologyRule 506(b)
▶$500KraisedSep 2019 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Yu-Shan YangExecutive Officer, Director
- Jen-Tang LuExecutive Officer, Director
- Amount sold
- $500K
- Minimum investment
- $1
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Vysioneer do?
- Vysioneer builds AI software that analyzes tumor lesions in medical imaging to assess treatment efficacy, aiming to make oncology clinical trials smaller and faster. It serves cancer researchers and drug developers by extracting all-lesion features and biomarkers that predict treatment outcomes.
- Who founded Vysioneer?
- Vysioneer was founded by Jen-Tang Lu in 2019.
- Who are Vysioneer's investors?
- Vysioneer's investors include Chaac Ventures.
- How much funding has Vysioneer raised?
- Vysioneer has disclosed $2.8M raised across 3 rounds.
- Where is Vysioneer headquartered?
- Vysioneer is headquartered in Cambridge, US.